Q4 2016 Holdings
Filed 2017-02-14 | 18 holdings | $217.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kite Pharma Inc | COM | 49803L109 | $105.7K | 2,358,084 | 48.6% |
| Costar Group Inc(CSGP) | COM | 22160N109 | $36.8K | 195,117 | 16.9% |
| Nantkwest Inc | COM | 63016Q102 | $25.7K | 4,485,495 | 11.8% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $13.7K | 2,799,790 | 6.3% |
| Mimedx Group Inc(MDXG) | COM | 602496101 | $9.6K | 1,080,365 | 4.4% |
| Barclays BK PLC | CALL | 06740Q902 | $8.2K | 320,600 | 3.8% |
| LPL Finl Hldgs Inc(LPLA) | COM | 50212V100 | $7.3K | 206,647 | 3.3% |
| Communications Sales&leas in | COM | 20341J104 | $4.1K | 163,000 | 1.9% |
| Ishares TR | CALL | 464287906 | $2.8K | 10,400 | 1.3% |
| Nanthealth Inc | COM | 630104107 | $2.4K | 238,828 | 1.1% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $671 | 41,324 | 0.3% |
| Ishares TR(IBB) | NASDQ BIOTEC ETF | 464287556 | $456 | 1,719 | 0.2% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $46 | 3,542 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $44 | 15,000 | 0.0% |
| General Mtrs Co(GM) | COM | 37045V100 | $28 | 800 | 0.0% |